Back to company

PHARMPROTECH HOLDING ApS: Financial statements 2020

CVR: 29174644

PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -6,000 and a net result of DKK 5,440,082 compared with DKK 1,912,671 the year before. Equity amounted to DKK 16,843,985. The solvency ratio was 64.5%.

Gross Profit
-6,000 kr.
Profit/Loss
5,440,082 kr.
Equity
16,843,985 kr.
Total Assets
26,119,573 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--6 t.5.4 mio.16.8 mio.-
2019--44 t.1.9 mio.11.6 mio.-
2018-212 t.2 mio.9.7 mio.-
2017-267 t.1.6 mio.7.7 mio.-
2016-259 t.1.8 mio.6.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMPROTECH HOLDING ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

PHARMPROTECH HOLDING ApS: The 2019 annual report is outJan 3, 2020

PHARMPROTECH HOLDING ApS has published its annual report for 2019. Gross profit came to DKK -43,500, and the net result was DKK 1,912,671.

About PHARMPROTECH HOLDING ApS

PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity amounted to DKK 38,132,221.